ArticleScientific reports2019

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Naotaka Hayasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.